Geode Capital Management, LLC Xenetic Biosciences, Inc. Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.31 - $0.73 $247 - $582	-798 Reduced 0.86%	91,545 $37,000
Q4 2022 Feb 13, 2023	SELL	$0.27 - $5.75 $69 - $1,483	-258 Reduced 0.28%	92,343 $26,000
Q2 2022 Aug 12, 2022	BUY	$0.6 - $1.14 $993 - $1,886	1,655 Added 1.82%	92,601 $74,000
Q4 2021 Feb 11, 2022	SELL	$1.27 - $2.08 $16,772 - $27,470	-13,207 Reduced 12.68%	90,946 $117,000
Q3 2021 Nov 12, 2021	BUY	$1.73 - $5.3 $92,802 - $284,307	53,643 Added 106.2%	104,153 $213,000
Q2 2021 Aug 13, 2021	BUY	$1.57 - $2.45 $30,220 - $47,160	19,249 Added 61.58%	50,510 $103,000
Q1 2021 May 12, 2021	BUY	$2.01 - $3.5 $36,334 - $63,269	18,077 Added 137.11%	31,261 $68,000
Q4 2020 Feb 12, 2021	BUY	$0.79 - $3.17 $10,415 - $41,793	13,184 New	13,184 $26,000

Ticker XBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,166,600
Market Cap $59.6M
Description
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-base...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.